Following the themes of "The Road to Pilot", "New Chapter", "New Future", "New Journey" and "New Dream" of the previous five conferences, the "6th Academic Conference on Clinical Cure of Chronic Hepatitis B" will be grandly opened in Xiamen, Fujian Province on May 18 with the theme of "Gathering Chinese Wisdom and Drawing a New Blueprint for Clinical Cure of Chronic Hepatitis B". At that time, experts in the field of liver diseases will gather to share the progress of clinical cure of chronic hepatitis B, hot and difficult issues, and witness a new chapter in the development of clinical cure of chronic hepatitis B.
The conference was co-sponsored by the China Foundation for Hepatitis Prevention and Control and the Liver Health Promotion Center of Zoomlion, and co-organized by Xiamen Tebao Bioengineering Co., Ltd. The conference mainly focused on the topic of clinical cure of chronic hepatitis B. In the morning, there were six themes and two discussion sessions in the main venue, sharing the latest research progress on clinical cure of chronic hepatitis B, antiviral treatment strategies for the prevention of HBV-related liver cancer, clinical cure and expert consensus on chronic hepatitis B in children, exploration of special outpatient clinics for clinical cure of hepatitis B, and the role of hepatitis B vaccine in the conversion of HBsAb to positive in clinically cured patients. Experts from Hainan Province, Fujian Province and Guangdong Province will be invited to explain in detail the strategies and progress of hepatitis prevention and control in each province. The session "Coping with Chronic Hepatitis B: Situation, Concept and Hope" will discuss the current situation of chronic hepatitis B prevention and treatment in mainland China from different perspectives. The "Roundtable" session will share diagnosis and treatment experience around a number of projects related to the clinical cure of hepatitis B.
In the afternoon, there will be three sub-venues: the first sub-venue is the Clinical Cure Forum for Low-level Treatment-Dominant Populations with HBsAg - Annual Meeting of the Starlight Project, which will share the latest progress and phased research results of the Starlight Project; The second session will be the sharing of practical experience in clinical cure, which will exchange treatment strategies and management experience of various chronic hepatitis B populations. Session 3 is a forum on complex liver diseases, which will provide an in-depth analysis of the difficulties and thorny problems in the treatment of chronic hepatitis B. Don't miss out on the content!
Gather the wisdom of China and draw a new blueprint for the clinical cure of chronic hepatitis B, let us work together to meet the challenges and work together to welcome the arrival of the era of comprehensive clinical cure of chronic hepatitis B!
Media Platform (40+) Professional Platform
Yulu Liver Lin, Yimaitong, Hepatobiliary Photography, Hepatobiliary and Pancreatic MDT, Infection Online, Chinese Journal of Hepatology, Journal of Clinical Hepatobiliary Diseases, Physician's Daily.
Media support
Weibo Health, Sina Medicine, People's Daily, Xinhua News Agency, Guangming.com, 21st Century Business Herald, Caixin Magazine, Douyin, Sina Weibo, Toutiao, People's Daily Online, Baidu, Sohu, NetEase, iQiyi, Youku, Tencent Video, Palai Help You, etc.
The replay of the previous live broadcast is all on the WeChat video account of the Journal of Clinical Hepatobiliary Diseases
关于本刊 About us
■ The first professional journal of hepatobiliary diseases in mainland China
■ 金色开放获取期刊（Golden OA）
■ International Committee of Medical Journal Editors (ICMJE) canonical journal■ Member journal of the International Society of Management and Technical Editors (ISMTE).
■ Included in 13 important international databases such as Embase and Scopus
■ 100 outstanding academic journals in China
■ China's high-quality scientific and technological journals
■ China's Top 100 University Science and Technology Journals
■ Journals included in the World Impact Index Report of Scientific and Technological Journals
■ Core Chinese journals of Peking University Library
■ Statistical source journal of Chinese scientific and technological papers
■ RCCSE China Authoritative Academic Journal (A+)
Official website: lcgdbzz.org
官方微信：lcgdbzz1985
Submission consultation: 0431-88782044
Review consultation: 0431-88783542
Reviewer application portal: Click to view